Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.

Objective: Large prospective studies have demonstrated that optimum glycemic control is not routinely achieved in clinical practice. Barriers to optimal insulin therapy include hypoglycemia, weight gain, and suboptimal initiation and dose titration. This study compared two treatment algorithms for i...

Descripción completa

Detalles Bibliográficos
Publicado en:Diabetes Care Vol. 28; no. 6; pp. 1282 - 1289
Autores principales: Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R, Davies, Melanie, Storms, Fred, Shutler, Simon, Bianchi-Biscay, Monique, Gomis, Ramon
Formato: clinical trial research tables/charts Journal Article
Publicado: American Diabetes Association Jun2005
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106380810&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106380810
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01495992
        1G7
      jtl: Diabetes Care
      issn: 01495992
      maglogo: N
    pubinfo:
      dt: Jun2005
      vid: 28
      iid: 6
      pid: 1367
      pub: American Diabetes Association
      place: Arlington, Virginia
    artinfo:
      ui:
        106380810
        106380810
        NLM15920040
        2009077406
        10.2337/diacare.28.6.1282
        NLM15920040
        106380810
      ppf: 1282
      ppct: 7
      formats:
      tig:
        atl: Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine.
      aug:
        au:
          Davies M
          Storms F
          Shutler S
          Bianchi-Biscay M
          Gomis R
          Davies, Melanie
          Storms, Fred
          Shutler, Simon
          Bianchi-Biscay, Monique
          Gomis, Ramon
        affil: University Hospitals of Leicester, Leicester Royal Infirmary, Infirmary Close, Leicester LE1 5WW, U.K
      sug:
        subj:
          Diabetes Mellitus, Type 2 Drug Therapy
          Insulin Administration and Dosage
          Blood Glucose Metabolism
          Glycemic Control
          Insulin Analogs and Derivatives
          Insulin Therapeutic Use
          Blood Glucose Drug Effects
          Glycated Hemoglobin Analysis
          Treatment Outcomes
          Hypoglycemia
          Clinical Trials
          Confidence Intervals
          Analysis of Covariance
          Middle Age
          Aged
          Female
          Male
          Funding Source
          Human
          Middle Aged: 45-64 years
          Aged: 65+ years
          Female
          Male
      ab: Objective: Large prospective studies have demonstrated that optimum glycemic control is not routinely achieved in clinical practice. Barriers to optimal insulin therapy include hypoglycemia, weight gain, and suboptimal initiation and dose titration. This study compared two treatment algorithms for insulin glargine initiation and titration: algorithm 1 (investigator led) versus algorithm 2 (performed by study subjects).Research Design and Methods: A prospective, multicenter (n = 611), multinational (n = 59), open-label, 24-week randomized trial in 4,961 (algorithm 1, n = 2,493; algorithm 2, n = 2,468) suboptimally controlled type 2 diabetic subjects.Results: At baseline, mean diabetes duration was 12.3 +/- 7.2 years, and 72% of subjects were pretreated with insulin. At end point, there was no significant difference in the incidence of severe hypoglycemia between algorithms 1 and 2 (0.9 vs. 1.1%). There was a significant reduction in HbA(1c) from 8.9 +/- 1.3 to 7.8 +/- 1.2%, with a greater decrease (P < 0.001) with algorithm 2 (-1.22%) versus algorithm 1 (-1.08%). Fasting blood glucose decreased from 170 to 110 mg/dl, with a greater decrease (P < 0.001) with algorithm 2 (-62 mg/dl) versus algorithm 1 (-57 mg/dl). Mean basal insulin dose increased from 22.9 +/- 15.5 to 43.0 +/- 25.5 IU, with a significant difference (P < 0.003) between algorithm 2 (21.6 IU) and algorithm 1 (18.7 IU).Conclusions: Glargine is safe and effective in improving glycemic control in a large, diverse population with longstanding type 2 diabetes. A simple subject-administered titration algorithm conferred significantly improved glycemic control with a low incidence of severe hypoglycemia compared with physician-managed titration.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N